BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 15548564)

  • 1. Glomerular podocytopathy in patients with systemic lupus erythematosus.
    Kraft SW; Schwartz MM; Korbet SM; Lewis EJ
    J Am Soc Nephrol; 2005 Jan; 16(1):175-9. PubMed ID: 15548564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis.
    Han TS; Schwartz MM; Lewis EJ
    Lupus; 2006; 15(2):71-5. PubMed ID: 16539276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.
    Salvatore SP; Barisoni LM; Herzenberg AM; Chander PN; Nickeleit V; Seshan SV
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):914-25. PubMed ID: 22461531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingerprint and other organised deposits in lupus nephritis.
    Hvala A; Kobenter T; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):711-5. PubMed ID: 11020962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function.
    Sinniah R; Feng PH
    Clin Nephrol; 1976 Aug; 6(2):340-51. PubMed ID: 782752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-Morphological Features and Outcomes of Lupus Podocytopathy.
    Hu W; Chen Y; Wang S; Chen H; Liu Z; Zeng C; Zhang H; Liu Z
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):585-92. PubMed ID: 26983707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular morphology in nephrotic heroin addicts.
    Grishman E; Churg J; Porush JG
    Lab Invest; 1976 Nov; 35(5):415-24. PubMed ID: 994459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria in membranous lupus nephritis: the pathology is in the podocyte.
    Desai N; Cimbaluk D; Lewis EJ; Whittier WL
    Lupus; 2013 Apr; 22(5):461-8. PubMed ID: 23428848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.
    Yumura W; Suganuma S; Nitta K; Sano Y; Uchida K; Nihei H
    Clin Exp Nephrol; 2004 Dec; 8(4):363-8. PubMed ID: 15619038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of systemic lupus erythematosus associated with minimal change nephrotic syndrome].
    Horita Y; Nazneen A; Cheng M; Razzaque MS; Namie S; Tadokoro M; Taura K; Miyazaki M; Ozono Y; Kohno S; Harada T; Taguchi T
    Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):759-64. PubMed ID: 9396245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin O treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist.
    Ito S; Kuriyama H; Iino N; Iguchi S; Shimada H; Ueno M; Narita I; Nakano M; Nishi S; Karasawa R; Gejyo F
    Clin Exp Nephrol; 2003 Dec; 7(4):290-5. PubMed ID: 14712359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis.
    Jeruc J; Jurcić V; Vizjak A; Hvala A; Babic N; Kveder R; Praprotnik S; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):702-6. PubMed ID: 11020960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of mesangial IgA deposits in kidney biopsies of pediatric patients: comparison with the clinical picture].
    Kern BE; di Rocco D; Lütschg J; Lüthy C; Zimmermann A; Gerber HA; Oetliker OH; Bianchetti MG
    Praxis (Bern 1994); 1995 Oct; 84(41):1158-64. PubMed ID: 7481326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA nephritis with nephrotic range proteinuria.
    Katz A; Walker JF; Landy PJ
    Clin Nephrol; 1983 Aug; 20(2):67-71. PubMed ID: 6616977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of lupus nephritis associated with minimal change nephrotic syndrome--comparison of various histological types of 67 cases with lupus nephritis].
    Okai T; Soejima A; Suzuki M; Yomogida S; Nakabayashi K; Kitamoto K; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):835-40. PubMed ID: 1479724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria and glomerular disease in Jamaica.
    Morgan AG; Shah DJ; Williams W; Forrester TE
    Clin Nephrol; 1984 Apr; 21(4):205-9. PubMed ID: 6733987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.